LB Pharmaceuticals Inc
LBRX
$23.91
$0.331.40%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/22/2026
-
MarketBeat
1/22/2026
-
Ticker Report
1/21/2026
-
The Fly
1/21/2026
-
GuruFocus
1/21/2026
-
Globe Newswire
1/17/2026
-
MarketBeat
1/16/2026
-
MarketBeat
1/15/2026
-
MarketBeat
1/12/2026
-
GuruFocus
1/12/2026
-
Globe Newswire
1/10/2026
-
Ticker Report
1/10/2026
-
MarketBeat
1/9/2026
-
The Fly
1/9/2026
-
TipRanks Financial Blog
1/6/2026
-
The Fly
1/6/2026
-
GuruFocus
1/6/2026
-
Globe Newswire
1/4/2026
-
Ticker Report
1/2/2026
-
MarketBeat
12/31/2025
-
MarketBeat
12/23/2025
-
MarketBeat
12/17/2025
-
Ticker Report
12/17/2025
-
The Fly
12/16/2025
-
TipRanks Financial Blog
12/16/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Aug 17 and 21 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 605 0300
Address
One Pennsylvania Plaza
New York, NY 10119
New York, NY 10119
Country
Year Founded
Business Description
Sector
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead...
more